Form 4: Moderna's Chief Legal Officer, Shannon Thyme Klinger, Reports Stock Transactions
SEC Form 4 Filing
Chief Legal Officer of Moderna, Shannon Thyme Klinger, reports acquisition and disposal of common stock and restricted stock units.
Summary
- On May 24, 2024, Shannon Thyme Klinger, Chief Legal Officer of Moderna, acquired 2,652 shares of common stock through the conversion of restricted stock units.
- Also on May 24, 2024, Klinger disposed of 11,919 shares.
- On May 28, 2024, Klinger disposed of 1,296 shares of common stock at a price of $162.4736 per share to cover tax withholding obligations related to the vesting of RSUs.
- Following these transactions, Klinger directly owns 10,623 shares of Moderna common stock and 7,957 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about insider trading activity.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency into the trading activities of key personnel at Moderna.
Stakeholder Impact
- Shareholders may be interested in the trading activity of company insiders as it can provide insights into management's perspective on the company's value and prospects.
Key Dates
| Date | Description |
|---|---|
| 05/24/2024 | Conversion of 2,652 Restricted Stock Units to Common Stock and disposal of 11,919 shares. |
| 05/27/2024 | 25% of restricted stock unit award vested. |
| 05/28/2024 | Sale of 1,296 shares to cover tax withholding obligations at $162.4736 per share. |
| 05/29/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.